CARDIOLOGY Bioprinting 3D heart pumps

Bioprinting 3D heart pumps

A concept that is gaining traction

BY MOLLY KUPFER, PHD, AND BRENDA OGLE, PHD

Heart disease is the leading cause of death worldwide, due in large part to the low regenerative capacity of the heart. With recent advances in stem cell biology, cardiac tissue engineering with human cells has emerged as an avenue to replace lost muscle after a cardiac event and to produce human models in vitro that can be used for disease modeling and testing of drugs and medical devices.

Early engineered heart tissues, pioneered in the late 1990s and early 2000s, consisted of geometrically simple structures (strips or rings) made by casting cardiomyocytes in a protein-based gel. While such tissues can recapitulate the contractility of cardiac muscle, their lack of geometric complexity limits their capacity to reflect clinically relevant characteristics of the heart. That is, while they can generate force, they possess no internal chambered structure with which to pump fluid.

“Printing” cardiac tissue

3D bioprinting, wherein structures are fabricated layer-by-layer utilizing a cellladen “bio-ink” as a substrate, has been proposed as a means to generate more geometrically complex tissues from the bottom up. The concept is gaining traction, as the ability to print tissues composed entirely of native proteins, cells, and/or biocompatible synthetic components is possible and accessible to many laboratories. Further, robust protocols have been developed for differentiating human-induced pluripotent stem cells (hiPSCs) into a variety of cell types, making it relatively easy to obtain cardiomyocytes ex vivo. However, while researchers have demonstrated the capacity to 3D-print entire heart organ models using biological materials, no one has yet demonstrated electromechanical function of cardiomyocytes within such a tissue.

The fact that macroscale contractile function has not yet been achieved in a 3D-printed, perfusable, chambered heart model reflects the challenges associated with handling mature cardiac muscle cells. More specifically, cardiomyocytes do not proliferate or migrate readily. For this reason, it is challenging to achieve the high cell density required for the formation of functional cell-cell junctions while maintaining the structural support needed for an enclosed chamber. Macroscale cardiac function relies on the electromechanical coupling of individual cardiomyocytes to form an organized, synchronously contracting tissue.

Traditionally, researchers have taken the approach of differentiating hiPSCs into cardiomyocytes in a tissue culture dish, and then collecting the differentiated cardiomyocytes and 3D printing with them. However, when hiPSCs are differentiated into cardiomyocytes this way, they tend to couple to each other and form a beating monolayer. To collect the cells from such an environment for further downstream applications typically requires one to break up these connections. Hence, to incorporate these cells into an engineered tissue, it is necessary to place them in a context where they can reform these interrupted connections. This is feasible in smaller, millimeterscale tissues, but it becomes challenging in larger, centimeter-scale tissues where the physical distance between cardiomyocytes after printing is too large to overcome.

HARDWOOD FLOORS ARE THE SUPERIOR CHOICE FOR FLOORING.

They do not hold dust, dander or pollen like carpet and are much easier to clean. They are surprisingly affordable and increase the value of your home. Properly maintained they should last 100 years.

We service metro area residential and commercial projects of all sizes. We offer a wide range of wood options and custom designs for new or existing homes. We also refinish existing wood floors.

Providing superior service, value and old-world craftsmanship for over 35 years. Please call to request a free estimate | 763-784-3000 | davesfloorsanding.com

A new strategy

Our alternative approach is to print stem cells, which are highly proliferative, and then induce differentiation of cardiomyocytes in situ following cell expansion. To enable this approach, we sought to develop a bio-ink formulation that:

1. Promotes hiPSC viability; 2. Enables hiPSC proliferation and subsequent differentiation into cardiomyocytes; and 3. Is amenable to printing complex structures.

Building on our understanding of how native extracellular matrix proteins modulate cell behavior, we developed an optimized bioink formulation composed of native proteins found in the heart. Some of these proteins were chemically modified to enable photo-crosslinking of the printed construct in order to maintain its geometric shape and structural integrity.

To generate the printing template, an MRI scan of a human heart was obtained and scaled to the size of a mouse heart such that the longest axis was

approximately 1.3 centimeters. In addition, the septum between ventricles was partially removed to provide a throughway such that unidirectional flow could be propagated through the printed structure for ease of nutrient delivery. The structure was further modified to limit the vascular connections to two major vessels extending from the top of the structure, corresponding to the aorta and vena cava from the digital template.

Prior to printing, hiPSCs were mixed into the bio-ink, which was then loaded into a syringe. The bio-ink was extruded from the nozzle using a commercial 3D printer and deposited layer-by-layer according to the print template. The tissues were printed into a gelatin support bath so that the relatively low-viscosity bio-ink would maintain its shape prior to photocrosslinking with blue light. After crosslinking, the gelatin bath was washed away, and the structures were cultured for two weeks to allow the stem cells to proliferate and fill the tissue gaps. The stem cells were subsequently differentiated into cardiomyocytes using a previously developed small molecule-based protocol.

This in situ differentiation approach enables the cells to form connections to each other as they differentiate, similar to what would happen in human development. The end result is a living pump that mimics the chambers and large vessel conduits of a native heart while housing viable, densely packed, and functional cardiomyocytes. These human chambered muscle pumps (hChaMPs) exhibit robust macroscale contraction. The cellular makeup is primarily cardiomyocytes (approximately 88%), but there are also other cardiac cell types present, specifically endothelial cells and smooth muscle cells. Importantly, the combined cardiac cell cocktail often fully circumvented the hChaMP, and the thickness of the wall was typically between 100 mm and 500 mm. However, at its thickest regions, we show that the muscularized region can exceed 500 mm, which is much higher than any previously reported values for engineered cardiac tissues.

Cells of the hChaMP robustly express protein markers of cardiomyocyte structural and functional maturation, including gap junctions, ion channels, and intracellular machinery associated with the sarcolemma and sarcoplasmic reticulum. These proteins are necessary for the efficient trafficking of ions, which enables contiguous impulse propagation through the tissue. Optical mapping enabled visualization of electrical signal propagation throughout the hChaMP in real time. The average spontaneous APD80 was 499.9 ± 83.5 milliseconds, and action potentials detected on the surface of the hChaMP reflected a dramatic and predicted response to altered pacing frequency and drug stimulation.

The location of the structure from which the activity was propagated was stochastic, sometimes from the large vessels, sometimes from a region near the large vessels, and sometimes near the apex. This outcome likely reflects the accumulation of pacemaker cells or immature cardiomyocytes with the capacity for spontaneous membrane depolarization in a given region that dominates and therefore initiates the response. However, in some cases the spontaneous source of depolarization could be overcome, and the directionality of propagation altered via electrical point stimulation at another location within the hChaMP.

Bioprinting 3D heart pumps to page 304

Property Management | New Development Asset Management | Project Management

mspcommercial.com

3Bioprinting 3D heart pumps from page 29

Potential applications

The primary benefit of a chambered tissue like the hChaMP is that it can replicate the pump function of the heart, allowing future researchers to trace and track what is happening at the cellular and molecular levels, introduce disease and damage to the model, and study the effects of medications and other therapeutics.

To determine pressure volume dynamics as a clinically relevant comparator for this new model system, a conductance catheter harboring a pressure transducer was inserted into one chamber of the hChaMP. The coupling of the pressure transducer with the conductance catheter enabled us to plot both pressure and volume simultaneously as a function of time, which was done for spontaneously contracting and isoproterenol-treated hChaMPs. Pressure-volume vs. time plots were used to generate pressurevolume loops, and from these stroke work could be determined despite the fact that there are no valves to resist emptying and filling. Using the pressurevolume setup, we were able to detect changes in beat rate corresponding to multiple concentrations of isoproterenol. The usual volume moved through the chambers was 0.5 mL and maximum volume moved through the chambers was 5.0 mL, which is approximately 25% that of the average stroke volume of an adult murine heart. Based on these values, we calculated an ejection fraction of 0.7% on average, with a maximum value of 6.5%.

Summing up

This advance represents a critical step toward generating macroscale tissues, akin to aggregate-based organoids, but with the critical advantage of harboring geometric structures essential to the pump function of cardiac muscle. The utility of this technology for the field of cardiology is access to a human model system that can sustain flow profiles and exhibit pressure-volume dynamics characteristic of the native heart. This model will therefore be useful for understanding remodeling associated with cardiac disease progression imposed by mechanical insult or genetic predisposition. It will also be useful for testing drug toxicity or efficacy and, given the scale, is amenable to the testing of medical devices, implantation to the heterotopic position in mice, and perhaps, one day, clinical transplantation.

Molly Kupfer, PhD, completed her doctorate in biomedical engineering at the University of Minnesota under the mentorship of Brenda Ogle, PhD. She has utilized human stem cells and 3D printing to generate living, contractile cardiac tissue for therapeutic use and in vitro modeling.

Brenda Ogle, PhD, is professor and head of biomedical engineering, professor of pediatrics, and director of the Stem Cell Institute at the University of Minnesota. Her research team investigates the impact of extracellular matrix proteins on stem cell behavior, especially in the context of the cardiovascular system.

Dr. Leah Schammel, Carris Health Physician

Carris Health

is the perfect match

Carris Health is a multi-specialty health network located in west central and southwest Minnesota and is the perfect match for healthcare providers who are looking for an exceptional practice opportunity and a high quality of life.

CURRENT OPPORTUNITIES AVAILABLE FOR BE/BC PHYSICIANS IN THE FOLLOWING SPECIALTIES:

• Anesthesiology • Dermatology • ENT • Family Medicine • Gastroenterology • General Surgery • Hospitalist • Internal Medicine • Nephrology • Neurology • OB/GYN • Oncology • Orthopedic Surgery • Psychiatry • Psychology • Pulmonary/

Critical Care • Rheumatology • Urology

Loan repayment assistance available.

FOR MORE INFORMATION:

Shana Zahrbock, Physician Recruitment Shana.Zahrbock@carrishealth.com (320) 231-6353 | carrishealth.com

3Clinical Service Lines from page 23

• Can I reconcile the two roles as being equally valuable in service to an integrated mission of patient care, and thereby minimize Another bit of counsel for the emerging physician leader is set in an the risk of seeing myself being caught between distinct and established social psychological theoretical framework (Julian Rotter, opposing forces (differing missions and obligations) as I make an 1975); “A person’s behavior is a function of their expectation for important decision? rewards that are valued, and the prevailing One final consideration; those most likely to social psychological dynamics that apply.” succeed, discover sooner rather than later that Change one, two or all three variables, and success as a leader is less dependent upon their motivation and/or actual behavior changes. abilities to make all the right decisions for those For physicians, thinking about venturing into the world of organizational leadership, some introspection is required. Four challenging, but practical issues are faced by virtually all The need to control all decisionmaking leads to a shrinking sphere of effective influence. they lead, than guiding those led to make their own right decisions based upon a clear vision and system of shared beliefs and mission. Physician physicians as they consider pursuing leadership leaders who fall in love with making all the career opportunities: decisions soon find themselves heading down an entropic professional path; the need to control all • What is it that pulls me toward leadership; decision-making leads to a shrinking sphere of what are the expected rewards that are more compelling for me effective influence. than dedication of my professional time and talents to full-time direct patient care? Daniel K. Zismer, Ph.D. is Co-Chair and CEO of Associated Eye Care • How will I best apply a reduced clinical service schedule for the Partners, LLC, Also, Endowed Scholar, Professor Emeritus and Chair, School of good of the organization and to ensure a satisfying and worthwhile clinical practice for me? Public Health, University of Minnesota. • Will the opinions of my peers matter as I make the decision to pursue a full or part-time career change?

Minneapolis VA Health Care System

Metro based opportunities include:

• Chief of General Internal Medicine • Chief of Cardiology • Cardiologist • Internal Medicine/Family Practice • Gastroenterologist • Psychiatrist • Tele-ICU (Las Vegas, NV) • Nephrologist Practice Opportunities throughout Greater Minnesota:

Our nation faces an unprecedented number of individuals who having served their country now receive health care benefits through the VA system. We offer an opportunity for you to serve those who have served their country providing community based health care in modern facilities with access to world-leading research and research opportunities. We provide outstanding benefits with less stress and burnout than many large system policies create. We allow you to do what you do, best – care for patients.

Ely VA Clinic

Current opportunities include:

Internal Medicine/Family Practice

Hibbing VA Clinic

Current opportunities include:

Internal Medicine/Family Practice

US citizenship or proper work authorization required. Candidates should be BE/BC. Must have a valid medical license anywhere in US. Background check required. EEO Employer. Possible Education Loan Repayment • Competitive Salary • Excellent Benefits • Professional Liability Insurance with Tail Coverage

For more information on current opportunities, contact: Yolanda Young: Yolanda.Young2@va.gov • 612-467-4964

One Veterans Drive, Minneapolis, MN 55417 • www.minneapolis.va.gov

3E-referral Solutions from page 19

questions in many of the categories inquire about sensitive and personal aspects of our patients lives and the screening process must be implemented with corresponding sensitivity. E-referral processes have demonstrated value for patients and there is more work to be done from a data analytics perspective to link SDOH screen data sets with outcomes based on clinical data.

Available Options

data and put this data on track to be exchanged and protected with appropriate consents and HIPAA compliance (we have minimal ICD-10 “Z codes,” but not enough granularity). One effort is the Gravity Project facilitated by the HL7 standards organization. As is the case with any set of health care data, there are emerging requests to collect, store, and mobilize SDOH data and optimize it through aggregation and analysis for many purposes. An electronic social needs referral There is much that can be done by better A small handful of vendors have been active is indeed akin to a prescription. understanding and addressing the 80% social in the national e-referral space such as Aunt determinants component of patient health that Bertha, Healthify, NowPow, UniteUs and a few is influenced and largely determined in the others. NowPow was the first to establish health community and outside the boundaries of the care clients in Minnesota (Minneapolis, St. 20% determined in the health care arena. Payment Paul metro), followed by Aunt Bertha. UniteUs models such as ACOs that enable flexibility in has recently announced a partnership with CyncHealth (formerly the how we help patients achieve their best possible health are just one avenue to Nebraska Health Information Initiative) and is seeking to establish clients connecting health care to community and taking advantage of the e-referral in Minnesota. While there are some general similarities in the workflows solutions that are rapidly being adopted across our state and nation. of these vendor products, each of them has a different approach and price point. Where one may focus on health care and referring to the community, Reid Haase, MA, is a Senior Healthcare IT Consultant, Practice Facilitator another may start by building a community coalition, then bringing health and works with Quality Improvement at Stratis Health. care providers in as stakeholders.

Just as there are efforts to enable EMRs to share data, the same need is under discussion in the national conversations around SDOH to standardize

“The Hub helped me get back on Social Security so that I could pay my bills while I continue to work on my health.”

Resources, tools, solutions.

With Disability Hub MN, you can put an essential resource directly in your patients’ hands. From explaining health coverage options to submitting medical benefit applications, Hub experts are uniquely positioned to support people with disabilities.